We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Resverlogix Completes Patient Recruitment for ASSERT Trial

News   Feb 08, 2010

 
Resverlogix Completes Patient Recruitment for ASSERT Trial
 
 
Advertisement
 

RELATED ARTICLES

RLF-100 Trial Shows Rapid Recovery From Respiratory Failure in Critically Ill Patients With COVID-19

News

A clinical trial of RLF-100 (aviptadil) has shown rapid recovery from respiratory failure in critically ill patients with COVID-19.

READ MORE

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Positive Results Reported for Phase 2 Study of Lyme Disease Vaccine Candidate

News

Positive initial results have been reported for the Phase 2 study of Lyme disease vaccine candidate VLA15.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE